当前位置: 首页 > 期刊 > 《中西医结合心脑血管病杂志》 > 2025年第4期
编号:2263430
血清MCP-1、NLR、SFRP及剩余SYNTAX积分预测急性心肌梗死病人PCI术后不良事件风险的效能
http://www.100md.com 2025年3月10日 中西医结合心脑血管病杂志 2025年第4期
经皮冠状动脉介入,EfficacyAnalysisofSerumMCP,1,"NLR,"SFRPandResidualSYNTAXScoreinPredic
    

    Efficacy Analysis of Serum MCP-1,"NLR,"SFRP and Residual SYNTAX Score in Predicting the Risk of Adverse Events in Patients with Acute Myocardial Infarction after PCI

    ZHAO Jianheng,"NIU Hongxia,"GUO Xumei,"MAO Yueran,"DAI Lili

    Electric Power Teaching Hospital of Capital Medical University, State Grid Corporation of China, Beijing Electric Power Hospital, Beijing 100073, China, E-mail: zhaojianheng0826@126.com

    Keywords"""acute myocardial infarction; percutaneous coronary intervention; major adverse cardiovascular events

    摘要""目的:分析血清单核细胞趋化蛋白-1(MCP-1)、中性粒细胞/淋巴细胞比值(NLR)、分泌型卷曲相关蛋白(SFRP)和剩余SYNTAX积分(rSS)预测急性心肌梗死(AMI)病人经皮冠状动脉介入(PCI)术后主要不良心血管事件(MACE)的效能 ......

您现在查看是摘要页,全文长 11286 字符